The Cancer Letter

Inside information on cancer research and drug development

In Brief

Emory Winship receives $1.34M Science Education Partnership Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Winship Cancer Institute of Emory University received a five-year $1.34 million Science Education Partnership Award from the National Institute of General Medical Sciences and the Office of Data Science Strategy at NIH to investigate whether problem-based learning will more effectively help to increase diversity in the biomedical research workforce and reduce health disparities. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Black patients who receive docetaxel for breast cancer experience less peripheral neuropathy than those who receive paclitaxel

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine have discovered that Black patients with breast cancer who are treated with docetaxel experience less peripheral neuropathy. Their findings represent an important shift in knowledge about a patient population who’ve historically been underrepresented in breast cancer research.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account